EX-23 2 vcnx-ex23_1.htm EX-23.1 EX-23

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-269385, 333-264236, 333-246322 and 333-246326 on Form S-3 and Registration Statement No. 333-226964 on Form S-8 of our report dated March 31, 2023, relating to the financial statements of Vaccinex, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2022.

/s/ Deloitte & Touche LLP

Rochester, New York

March 31, 2023